Discover Great Companies Discover Great Clients
Popularity  5.8万   |   Followers  8   |   Likes  22   |   Feedback  9 Claim this company

Committed to addressing unmet medical needs in three major disease are

No.651 Hangzhou City Popularity Ranking No.81 Xiaoshan District Zhejiang P No.3 Chemistry APIs No.4 Chemistry Pharmaceuticals No.5 Generic Drugs No.8 Chemical Raw Materials No.8 Pharmaceutical APIs No.8 Antibodies No.9 Peptides No.9 APIs No.10 Yuan Yan Yao No.10 Innovative Drugs Products No.12 Pharmaceutical R&D No.13 Innovative Drugs 高新技术企业 省级专精特新中小企业 市级创新型中小企业 省级高新技术企业 科技型中小企业 省科技型中小企业 药品生产许可证
More

Company Overview

  • Nature: Listed Company Size: 100-499 employees Founded: 13年
  • Industry: Pharmaceuticals/Biotechnology 、 Raw Materials and Processing
  • Full name: Ascletis BioScience Co., Ltd. (Hangzhou)。

Development Stage

  • Stage: B轮, 1亿美元。
  • Ranking: Ranked #651 in Hangzhou City by popularity Ranked #3 in Hangzhou Chemistry APIs Company by popularity Ranked #4 in Hangzhou Chemistry Pharmaceuticals Company by popularity Ranked #5 in Hangzhou Generic Drugs Company by popularity Ranked #8 in Hangzhou Chemical Raw Materials Company by popularity
  • Honors: 高新技术企业 省级专精特新中小企业 According to algorithm
  • News: 2026-02-11:歌礼制药:选定口服胰淀素受体激动剂多肽ASC36进行临床开发。
  • Salary: 66.1% of positions earn 10-30K, In 2026 vs last yeargrew by 12%.。Master's salary: ¥26.8K.
  • R&D: "Other (R&D and Technical)" demand: 23.2%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 23.2%, "Medical & Health/Beauty & Healthcare": 14.3%。
  • Recruiting: In 2026 vs 2025grew by 114%. Demand for highly educated talent: Master's: 9.
  • Requirement: Education: 本科 leads with 63.2%. Experience: 3-5年 leads with 36.8%.
  • Region: Distributed across 2 regions, 杭州: 72.1%, 绍兴: 26.5%, 苏州: 1.5%.

About the Company

[Summary] Committed to addressing unmet medical needs in three major disease are

Ascletis is a fully integrated value-chain biotechnology company focused on the development and commercialization of drugs expected to be best-in-class and first-in-class for metabolic diseases. Leveraging its proprietary AI-assisted structure-based drug discovery (AISBDD), Ultra-Long-Acting Platform (ULAP) technology, and oral peptide transport enhancement technology (POTENT), Ascletis has independently developed multiple small molecule and peptide drug candidates, including its core project ASC30, an investigational small molecule GLP-1R agonist that can be administered orally once daily or subcutaneously once monthly to once quarterly as a weight loss treatment and weight loss maintenance therapy for long-term weight management; ASC36, an amylin receptor agonist peptide; ASC35, a once-monthly subcutaneous GLP-1R/GIPR dual-target agonist peptide; ASC37, a GLP-1R/GIPR/GCGR triple-target agonist peptide; ASC39, a potent oral small molecule amylin receptor agonist similar to eloralintide with selectivity for amylin; and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1RA) and ASC39 (amylin receptor agonist) for long-term weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK). For more information, please visit the website: *.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Ascletis Financing History (2 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1亿美元
  • Investor: 康桥资本,分众传媒,高盛集...

Ascletis How Fast Is Hiring Growing? (26 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 53%
  • 2024: Down 64%
  • 2023: Down 20%
  • 2022: Up 8%
Ascletis Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Ascletis Campus Recruitment & Advanced Degree Talent Demand
Master's 9
Note: How fast is hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? Ascletis2026: 62 openings (up 114%), 2025: 29 openings (up 53%), 2024: 19 openings (down 64%), 2023: 53 openings (down 20%), 2022: 66 openings (up 8%), 2021: 61 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Ascletis Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 75%
  • 2024: Down 43%
  • 2023: Down 13%
  • 2022: Up 60%
Ascletis Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? AscletisMaster's recruitment over the years: 2025: 1 openings (down 75%), 2024: 4 openings (down 43%), 2023: 7 openings (down 13%), 2022: 8 openings (up 60%), 2021: 5 openings. Ascletis master talent ranking in Hangzhou: #190, Ascletis master salary mostly around 20-50K.

Ascletis Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Ascletis Doctoral Hiring by Year: 2024 — 4 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Ascletis BioScience Co., Ltd. (Hangzhou) growing? AscletisDoctorate recruitment over the years: 2024: 1 openings (down 43%), 2023: 5 openings (down 13%), 2022: 5 openings (up 60%), 2021: 1 openings.

Ascletis R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Ascletis BioScience Co., Ltd. (Hangzhou)? Based on an analysis of Ascletis's job postings over the past year, "Other (R&D and Technical)" demand: 23.2%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 23.2%, "Medical & Health/Beauty & Healthcare": 14.3%, "Scientific Research": 14.3%, "Computer/Network/Technology": 5.4%, "Mechanical/Instrumentation": 3.6%. For reference only.

Ascletis — What Are the Salaries Like? (56 records)

Manage
Ascletis Salary Overview
salary range: 2K - 50K, 66.1% of roles pay ¥10-30K
Note: salary statistics are based on 56 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Ascletis BioScience Co., Ltd. (Hangzhou)?Ascletis66.1% of positions earn 10-30K, Undergraduate salary: ¥。Hangzhou salary ranking top 30,经营管理类 average salary ¥19.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Ascletis

(More)
Are salaries high at Ascletis BioScience Co., Ltd. (Hangzhou)? We provide: Researcher, President, QC, Analyst, Operations, 临床, Recruitment Supervisor, Senior Specialist, Senior Supervisor, DM, Cashier, Organic Synthesis Chemist, 注册经理, Administrative Specialist, Quality, Procurement, CMC Director, ehs, IT Manager, QA. Click to view detailed salary analysis by job.

Ascletis honors, qualifications & industry associations

Job Category

  • 经营管理类
    36.8% of total 36.8%
  • 生物/制药/化工/环保类
    23.5% of total 23.5%
  • 其他(研发和技术类)
    22.1% of total 22.1%
  • 质量管理类
    16.2% of total 16.2%

Education

  • 本科
    63.2% of total 63.2%
  • 硕士
    25% of total 25%
  • 大专
    10.3% of total 10.3%
  • 不限
    1.5% of total 1.5%

Experience

  • 3-5年
    36.8% of total 36.8%
  • 5-10年
    32.4% of total 32.4%
  • 1-3年
    23.5% of total 23.5%
  • 不限
    7.4% of total 7.4%
View Detailed Analysis

What does Ascletis BioScience Co., Ltd. (Hangzhou) require? Who is Ascletis hiring? Ascletis recruitment: 经营管理类占比最多占36.8%,其次是生物/制药/化工/环保类占23.5%. What education can get in at Ascletis? 本科占比最多占63.2%,其次是硕士占25%. High education required at Ascletis? 硕士占25%. Work experience required at Ascletis? 3-5年占比最多占36.8%,其次是5-10年占32.4%. Where are the job locations at Ascletis? 杭州占比最多占72.1%,其次是绍兴占26.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 18,060.0162万(美元)
Legal Representative: JUDY HEJINGDAO WU
Date Established:
Credit Code: 913301000639922113
Registered Address: 浙江省杭州市萧山区经济技术开发区明星路371号3幢1201室

Partners & Suppliers

国药控股成为歌礼生物丙肝药物等产品的全国经销商 Source
合作客户 经销商/渠道
双方共同开发抗PD-L1抗体ASC22用于非酒精性脂肪性肝炎(NASH) Source
供应商 联合研发/技术合作
罗氏获得歌礼生物丙肝药物达诺瑞韦(戈诺卫)在中国以外地区的独家开发和商业化权利 Source
合作客户 技术授权/战略合作

People who follow Ascletis also follow

Ascletis Competitors (Similar Companies)

“Medium-to-high-end high-reliability transmission products and services”
阀门定位器 阀门 自动化设备 执行器
大健康 产后康复 小儿推拿 健康管理
“To become a century-old enterprise with responsibility, industry statu”
医学实验室 应急 成果转化 生物转化
“Is an innovative filtration enterprise, focusing on the development an”
能源 储能 光伏 分布式光伏
“High-quality dataset production and operation service provider”
“Committed to the advancement of technology and market in the embedded ”
服装/服饰 家具 针织 家纺
“A specialized, group-oriented and international energy and power engin”
精准医疗 药物研发 免疫治疗 科学研究
供应链管理 国际货运 仓储 国际货运代理
“Construction and development of smart lighting, smart cultural tourism”
物业 社区管理

Discover Great Companies, Discover Great Clients

杭州公司名录 杭州“Xiaoshan District”公司名录 杭州“生物科技/生物工程”公司名录 杭州“制药/药业”公司名录 杭州“医药”公司名录 杭州“抗体”公司名录 杭州“生物医药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates